
    
      This research trial will involve all available subjects who received treatment in DURECT
      Protocol C803-017. All subjects will have the same follow-up safety assessments performed. No
      experimental treatment will be given in this trial. Subjects, Investigators, and caregivers
      will remain blinded to the treatment subjects received in the previous trial.
    
  